Business Context and Reporting Period
This Form 8-K Current Report from vTv Therapeutics Inc. covers events occurring on April 30, 2018, and May 2, 2018. The filing addresses a regulatory compliance issue with The NASDAQ Stock Market LLC and reports the results of the Company's 2018 Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the Market Value of Listed Securities (MVLS), which fell below the $50 million threshold required by NASDAQ Rule 5450(b)(2)(A).
Material Changes and Events
- NASDAQ Non-Compliance: On May 2, 2018, the Company received notice from NASDAQ that its MVLS had been below $50 million for 30 consecutive business days. The Company has 180 calendar days (until October 29, 2018) to regain compliance by maintaining an MVLS of at least $50 million for 10 consecutive business days. Failure to comply may result in delisting.
- Annual Meeting Results: On April 30, 2018, stockholders voted to elect eight directors to the Board of Directors and ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2018.
Guidance, Outlook, and Risks
Management intends to actively monitor the MVLS and is evaluating available options to regain compliance with NASDAQ listing standards. The primary risk identified is the potential removal of the Company's Class A Common Stock from The NASDAQ Global Market if compliance is not achieved within the 180-day period. No financial guidance or outlook was provided in this filing.
Investor Verification Checklist
- Verify the current Market Value of Listed Securities (MVLS) to assess progress toward the $50 million compliance threshold.
- Monitor the Company's public disclosures for updates on strategies to regain NASDAQ compliance before the October 29, 2018 deadline.
- Review the composition of the newly elected Board of Directors and their backgrounds.
- Confirm the ratification of Ernst & Young LLP as the auditor for the 2018 fiscal year.